PragasamA.K., ShankarC., VeeraraghavanB., BiswasI., NabarroL.E., InbanathanF.Y., GeorgeB., and VergheseS.. 2017. Molecular mechanisms of colistin resistance in Klebsiella pneumoniae Causing Bacteremia from India—a first report. Front. Microbiol. 7:2135.
2.
SinghS., PathakA., KumarA., RahmanM., SinghA., Gonzalez-ZornB., and PrasadK.N.. 2018. Emergence of chromosome-borne colistin resistance gene mcr-1 in clinical isolates of Klebsiella pneumoniae from India. Antimicrob. Agents Chemother. 62:e01885-17.
3.
SrijanA., MargulieuxK.R., RuekitS., SnesrudE., MaybankR., SerichantalergsO., KormaneeR., SukhchatP., SriyabhayaJ., HinkleM., and CrawfordJ.M.. 2018. Genomic characterization of nonclonal mcr-1-positive multidrug-resistant Klebsiella pneumoniae from clinical samples in Thailand. Microb. Drug Resist. 24:403–410.
4.
MendesA.C., NovaisA., CamposJ., RodriguesC., SilvaT., SantosC., AntunesP., RamosH., and PeixeL.. 2018. Emergence of mcr-1 among KPC-3-producing Klebsiella pneumoniae in hospitalized patients in Portugal: silent spread of a loud foe. In Online Lecture Library of the 28th ECCMID European Congress of Clinical Microbiology and Infectious Diseases, Madrid, Spain.
5.
CannatelliA., GianiT., D'AndreaM.M., Di PilatoV., ArenaF., ConteV., TryfinopoulouK., VatopoulosA., RossoliniG.M.; and COLGRIT Study Group. 2014. MgrB inactivation is a common mechanism of colistin resistance in KPC carbapenemase-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58:5696–5703.
6.
EspositoE.P., CervoniM., BernardoM., CrivaroV., CuccurulloS., ImperiF., and ZarrilliR.. 2018. Molecular epidemiology and virulence profiles of colistin-resistant Klebsiella pneumoniae blood isolates from the Hospital Agency “Ospedale dei Colli,” Naples, Italy. Front. Microbiol. 9:1463.
7.
BerglundB., HoangN.T., TärnbergM., LeN.K., SvartströmO., KhuD.T., NilssonM., LeH.T., WelanderJ., OlsonL., and LarssonM.. 2018. Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam. Int. J. Antimicrob Agents. 51:789–793.
8.
BakthavatchalamY.D., PragasamA.K., BiswasI., and VeeraraghavanB.. 2017. Polymyxin susceptibility testing, interpretative breakpoints and resistance mechanism: an update. J. Global Antimicrob. Resist. 12:124–136.
9.
OlaitanA.O., DieneS.M., KempfM., BerrazegM., BakourS., GuptaS.K., ThongmalayvongB., AkkhavongK., SomphavongS., PaboribouneP., and ChaisiriK.. 2014. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int. J. Antimicrob. Agents. 44:500–507.
10.
ZavasckiA.P., GirardelloR., MagagninC.M., AntochevisL.C., MacielR.A., PalmeiroJ.K., and GalesA.C.. 2018. Emergence of polymyxin B resistance in a polymyxin B-susceptible KPC-producing Klebsiella pneumoniae causing bloodstream infection in a neutropenic patient during polymyxin B therapy. Diagn. Microbiol. Infect. Dis. 90:134–138.
11.
ÁlvarezV.E., CamposJ., GalianaA., BorthagarayG., CentrónD., and VillalbaC.M.. 2018. Genomic analysis of the first isolate of KPC-2-producing Klebsiella pneumoniae from Uruguay. J Global Antimicrob. Resist. 15:109–110.
12.
da SilvaH.R., VilelaM.A., AlmeidaA.C., and de MoraisM.M.. 2018. Colistin-resistant KPC-2–producing Klebsiella pneumoniae ST423 harboring an IS5-like element in the mgrB gene isolated from cerebrospinal fluid. Diagn. Microbiol. Infect. Dis. 91:184–185.
13.
GiordanoC., BarniniS., TsioutisC., ChlebowiczM.A., ScoulicaE.V., GikasA., RossenJ.W., FriedrichA.W., and BathoornE.. 2018. Expansion of KPC-producing Klebsiella pneumoniae with various mgrB mutations giving rise to colistin resistance: the role of ISL3 on plasmids. Int. J. Antimicrob Agents. 51:260–265.
14.
PoirelL., JayolA., BontronS., VillegasM.V., OzdamarM., TürkogluS., and NordmannP.. 2014. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J. Antimicrob. Chemotherapy. 70:75–80.
AiresC.A., PereiraP.S., AsensiM.D., and Carvalho-AssefA.P.. 2016. MgrB mutations mediating polymyxin B resistance in Klebsiella pneumoniae isolates from rectal surveillance swabs in Brazil. Antimicrob. Agents Chemother. 12:AAC-01456.
17.
KumarA., BiswasL., OmgyN., MohanK., VinodV., SajeevA., NairP., SinghS., and BiswasR.. 2018. Colistin resistance due to insertional inactivation of the mgrB in Klebsiella pneumoniae of clinical origin: First report from India: Resistencia a colistina debido a inactivación insercional del gen mgrB en aislados clínicos de Klebsiella pneumoniae: Primera notificación en India. Revista Española de Quimioterapia. 31:406.
ZamanT.U., AlbladiM., SiddiqueM.I., AljohaniS.M., and BalkhyH.H.. 2018. Insertion element mediated mgrB disruption and presence of ISKpn28 in colistin-resistant Klebsiella pneumoniae isolates from Saudi Arabia. Infect Drug Resist. 11:1183.
20.
WandM.E., BockL.J., and SuttonJ.M.. 2017. Retention of virulence following colistin adaptation in Klebsiella pneumoniae is strain-dependent rather than associated with specific mutations. J. Med Microbiol. 66:959–964.
21.
JaidaneN., BonninR.A., MansourW., GirlichD., CretonE., CotellonG., ChaouchC., BoujaafarN., BouallegueO., and NaasT.. 2018. Genomic insights into colistin-resistant Klebsiella pneumoniae from a Tunisian teaching hospital. Antimicrob. Agents Chemother, 62:e01601–17.
